BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17875605)

  • 1. Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.
    Kemmner W; Wan K; Rüttinger S; Ebert B; Macdonald R; Klamm U; Moesta KT
    FASEB J; 2008 Feb; 22(2):500-9. PubMed ID: 17875605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway.
    Yoshioka E; Chelakkot VS; Licursi M; Rutihinda SG; Som J; Derwish L; King JJ; Pongnopparat T; Mearow K; Larijani M; Dorward AM; Hirasawa K
    Theranostics; 2018; 8(8):2134-2146. PubMed ID: 29721068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.
    Teng L; Nakada M; Zhao SG; Endo Y; Furuyama N; Nambu E; Pyko IV; Hayashi Y; Hamada JI
    Br J Cancer; 2011 Mar; 104(5):798-807. PubMed ID: 21304523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.
    Palasuberniam P; Kraus D; Mansi M; Braun A; Howley R; Myers KA; Chen B
    Photochem Photobiol; 2019 Jul; 95(4):1052-1059. PubMed ID: 30767226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
    Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
    Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
    Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
    J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to Measure the Inhibition of ABCG2 Transporter and Ferrochelatase Activity to Enhance Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Tumor Detection and Resection.
    Mansi M; Howley R; Chen B
    Methods Mol Biol; 2022; 2394():823-835. PubMed ID: 35094360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transcriptional regulation of the expression of ferrochelatase by its variant mRNA.
    Sakaino M; Kataoka T; Taketani S
    J Biochem; 2009 Jun; 145(6):733-8. PubMed ID: 19251765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
    Nakanishi T; Ogawa T; Yanagihara C; Tamai I
    J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.
    Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J
    Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
    Barman-Aksözen J; Minder EI; Schubiger C; Biolcati G; Schneider-Yin X
    Blood Cells Mol Dis; 2015 Jan; 54(1):71-7. PubMed ID: 25179834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protoporphyrin IX tracer fluorescence modulation for improved brain tumor cell lines visualization.
    Piffaretti D; Burgio F; Thelen M; Kaelin-Lang A; Paganetti P; Reinert M; D'Angelo ML
    J Photochem Photobiol B; 2019 Dec; 201():111640. PubMed ID: 31734545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of peptide transporter 1 has a positive correlation in protoporphyrin IX accumulation induced by 5-aminolevulinic acid with photodynamic detection of non-small cell lung cancer and metastatic brain tumor specimens originating from non-small cell lung cancer.
    Omoto K; Matsuda R; Nakai Y; Tatsumi Y; Nakazawa T; Tanaka Y; Shida Y; Murakami T; Nishimura F; Nakagawa I; Motoyama Y; Nakamura M; Fujimoto K; Hiroyuki N
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():309-316. PubMed ID: 30639584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity.
    Hefti M; Holenstein F; Albert I; Looser H; Luginbuehl V
    Photochem Photobiol; 2011; 87(1):235-41. PubMed ID: 21073472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo tumor imaging using a novel RNAi-based detection mechanism.
    Wan K; Ebert B; Voigt J; Wang Q; Dai Y; Haag R; Kemmner W
    Nanomedicine; 2012 May; 8(4):393-8. PubMed ID: 22349098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of ABCB6 enhances protoporphyrin IX accumulation and photodynamic effect in human glioma.
    Zhao SG; Chen XF; Wang LG; Yang G; Han DY; Teng L; Yang MC; Wang DY; Shi C; Liu YH; Zheng BJ; Shi CB; Gao X; Rainov NG
    Ann Surg Oncol; 2013 Dec; 20(13):4379-88. PubMed ID: 22688660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEK reduces cancer-specific PpIX accumulation through the RSK-ABCB1 and HIF-1α-FECH axes.
    Chelakkot VS; Liu K; Yoshioka E; Saha S; Xu D; Licursi M; Dorward A; Hirasawa K
    Sci Rep; 2020 Dec; 10(1):22124. PubMed ID: 33335181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin.
    Ohgari Y; Nakayasu Y; Kitajima S; Sawamoto M; Mori H; Shimokawa O; Matsui H; Taketani S
    Biochem Pharmacol; 2005 Dec; 71(1-2):42-9. PubMed ID: 16288996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells.
    Ogino T; Kobuchi H; Munetomo K; Fujita H; Yamamoto M; Utsumi T; Inoue K; Shuin T; Sasaki J; Inoue M; Utsumi K
    Mol Cell Biochem; 2011 Dec; 358(1-2):297-307. PubMed ID: 21748335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.